These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21336113)

  • 1. Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in mice.
    Altaweel L; Chen Z; Moayeri M; Cui X; Li Y; Su J; Fitz Y; Johnson S; Leppla SH; Purcell R; Eichacker PQ
    Crit Care Med; 2011 Jun; 39(6):1439-47. PubMed ID: 21336113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis.
    Cui X; Li Y; Moayeri M; Choi GH; Subramanian GM; Li X; Haley M; Fitz Y; Feng J; Banks SM; Leppla SH; Eichacker PQ
    J Infect Dis; 2005 Feb; 191(3):422-34. PubMed ID: 15633102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule inhibitors of lethal factor protease activity protect against anthrax infection.
    Moayeri M; Crown D; Jiao GS; Kim S; Johnson A; Leysath C; Leppla SH
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4139-45. PubMed ID: 23774434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective antigen antibody augments hemodynamic support in anthrax lethal toxin shock in canines.
    Barochia AV; Cui X; Sun J; Li Y; Solomon SB; Migone TS; Subramanian GM; Bolmer SD; Eichacker PQ
    J Infect Dis; 2012 Mar; 205(5):818-29. PubMed ID: 22223857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral Expression of a Bispecific VHH-Based Neutralizing Agent That Targets Protective Antigen Provides Prophylactic Protection from Anthrax in Mice.
    Moayeri M; Tremblay JM; Debatis M; Dmitriev IP; Kashentseva EA; Yeh AJ; Cheung GY; Curiel DT; Leppla S; Shoemaker CB
    Clin Vaccine Immunol; 2016 Jan; 23(3):213-8. PubMed ID: 26740390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lethal factor, but not edema factor, is required to cause fatal anthrax in cynomolgus macaques after pulmonary spore challenge.
    Hutt JA; Lovchik JA; Drysdale M; Sherwood RL; Brasel T; Lipscomb MF; Lyons CR
    Am J Pathol; 2014 Dec; 184(12):3205-16. PubMed ID: 25285720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax.
    Peterson JW; Comer JE; Noffsinger DM; Wenglikowski A; Walberg KG; Chatuev BM; Chopra AK; Stanberry LR; Kang AS; Scholz WW; Sircar J
    Infect Immun; 2006 Feb; 74(2):1016-24. PubMed ID: 16428748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
    Jang J; Cho M; Lee HR; Cha K; Chun JH; Hong KJ; Park J; Rhie GE
    Biochim Biophys Acta; 2013 Mar; 1830(3):2804-12. PubMed ID: 23201204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse monoclonal antibodies to anthrax edema factor protect against infection.
    Leysath CE; Chen KH; Moayeri M; Crown D; Fattah R; Chen Z; Das SR; Purcell RH; Leppla SH
    Infect Immun; 2011 Nov; 79(11):4609-16. PubMed ID: 21911463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of anthrax toxins with a bispecific monoclonal antibody that cross reacts with edema factor as well as lethal factor of Bacillus anthracis.
    Kulshreshtha P; Bhatnagar R
    Mol Immunol; 2011 Sep; 48(15-16):1958-65. PubMed ID: 21704379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model.
    Sherer K; Li Y; Cui X; Li X; Subramanian M; Laird MW; Moayeri M; Leppla SH; Fitz Y; Su J; Eichacker PQ
    Crit Care Med; 2007 Jun; 35(6):1560-7. PubMed ID: 17452924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacillus anthracis protective antigen kinetics in inhalation spore-challenged untreated or levofloxacin/ raxibacumab-treated New Zealand white rabbits.
    Corey A; Migone TS; Bolmer S; Fiscella M; Ward C; Chen C; Meister G
    Toxins (Basel); 2013 Jan; 5(1):120-38. PubMed ID: 23344456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-glycosylated, plant-produced human monoclonal antibody against anthrax protective antigen protects mice and non-human primates from B. anthracis spore challenge.
    Mett V; Chichester JA; Stewart ML; Musiychuk K; Bi H; Reifsnyder CJ; Hull AK; Albrecht MT; Goldman S; Baillie LW; Yusibov V
    Hum Vaccin; 2011; 7 Suppl():183-90. PubMed ID: 21270531
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Cui X; Wang J; Li Y; Couse ZG; Risoleo TF; Moayeri M; Leppla SH; Malide D; Yu ZX; Eichacker PQ
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H36-H51. PubMed ID: 33064559
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional characterization and evaluation of protective efficacy of EA752-862 monoclonal antibody against B. anthracis vegetative cell and spores.
    Majumder S; Das S; Kingston J; Shivakiran MS; Batra HV; Somani VK; Bhatnagar R
    Med Microbiol Immunol; 2020 Apr; 209(2):125-137. PubMed ID: 31811379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax.
    Chen Z; Schneerson R; Lovchik JA; Dai Z; Kubler-Kielb J; Agulto L; Leppla SH; Purcell RH
    Clin Vaccine Immunol; 2015 Aug; 22(8):902-8. PubMed ID: 26041039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen.
    Chen Z; Moayeri M; Zhou YH; Leppla S; Emerson S; Sebrell A; Yu F; Svitel J; Schuck P; St Claire M; Purcell R
    J Infect Dis; 2006 Mar; 193(5):625-33. PubMed ID: 16453257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of Anthrax.
    Tang Q; Xiong S; Liang X; Kuai X; Wang Y; Wang C; Feng Z; Zhu J
    BMC Infect Dis; 2018 Dec; 18(1):640. PubMed ID: 30526504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive Immunotherapy Protects against Enteric Invasion and Lethal Sepsis in a Murine Model of Gastrointestinal Anthrax.
    Huang B; Xie T; Rotstein D; Fang H; Frucht DM
    Toxins (Basel); 2015 Sep; 7(10):3960-76. PubMed ID: 26426050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.